IgG2b NEGATIVE CONTROL
Cat# OOSA10386
Size : 1mg
Marca : Aviva Systems Biology
Contatta il distributore locale :
Telefono : +1 850 650 7790
| Datasheets/Manuals | Printable datasheet for IgG2b NEGATIVE CONTROL (OOSA10386) |
|---|
| Predicted Species Reactivity | Negative Control |
|---|---|
| Product Format | Liquid. Phosphate buffered saline |
| Isotype | IgG2b |
| Application | FC, IHC-P, IP, WB |
| Additional Information | Approx Protein Conc: IgG concentration 1.0 mg/ml Buffer solution: Phosphate buffered saline pH7.4 |
| :: | Label Protein Molar Ratio: Purified IgG prepared by affinity chromatography on Protein A Preservative: None present |
| Reconstitution and Storage | -20°C |
| Concentration | 1 mg/ml |
| Specificity | This product is a mouse IgG2b monoclonal antibody arising from a spontaneous murine plasmacytoma. The antibody does not react with any human cell surface markers, and may therefore be used as an isotype matched negative control reagent to assess the level of non-specific binding of mouse IgG2b monoclonal antibodies to human cells. Test results show that This product is also suitable for use as a negative control with cow, sheep, pig, dog, rat and guinea-pig tissues. |
| Predicted Homology Based on Immunogen Sequence | Negative Control |
| Purification | Protein A Purified |
| Reference | 1. Grant, A. et al. (2002) Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am. J. Pathol. 160: 1445 - 1455. 2. Zheng, X. et al. (2002) Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-KappaB-dependent and-independent pathways. Immunology. 107:306-315. |
|---|---|
| Description of Target | MOUSE IgG2b NEGATIVE CONTROL:Azide Free |